Repeatability of Lung Density Measurements with Low-Dose Computed Tomography in Subjects with &agr;-1-Antitrypsin Deficiency–Associated Emphysema

Stolk J, Dirksen A, van der Lugt A, et al. Repeatability of lung density measurements with low-dose computed tomography in subjects with &agr;-1-antitrypsin deficiency–associated emphysema. Invest Radiol 2001;36:648-651. rationale and objectives. Multislice computed tomography (MSCT) of the lungs provides a new opportunity for longitudinal assessment of lung densities because of shorter scan duration. The aim of the present study was to assess the intraindividual variation of lung densities measured by MSCT of patients with emphysema. methods.Ten patients with emphysema participated in a study in which MSCT was obtained on two occasions, approximately 2 weeks apart. Scanning parameters were 140 kV, 20 mAs, 4 × 2.5-mm collimation, and effective slice thickness of 2.5 mm. Lung density was measured as the 15th percentile point and the relative area below −910 Hounsfield units (HU) by using Pulmo-LKEB software. results.The mean difference of the 15th percentile point was −1.29 ± 3.2 HU, and that for the relative area below the −910-HU parameter was −1.02% ± 3.09%. Intraclass coefficients of variation were 0.96 (0.86–0.99) and 0.94 (0.8–0.98), respectively (95% confidence interval). conclusions.Lung density parameters of emphysema derived by MSCT provide an opportunity for analysis of the treatment effects of new drugs on the progression of emphysema.

[1]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[2]  J. Best,et al.  CT measurements of lung density in life can quantitate distal airspace enlargement--an essential defining feature of human emphysema. , 1988, The American review of respiratory disease.

[3]  G J Kemerink,et al.  Reproducibility of spirometrically controlled CT lung densitometry in a clinical setting. , 1998, The European respiratory journal.

[4]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[5]  H A Vrooman,et al.  A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.

[6]  M. Hughes,et al.  Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved? , 1997, The European respiratory journal.

[7]  A A Bankier,et al.  Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. , 1999, Radiology.

[8]  P. Enright,et al.  Spirometry in the Lung Health Study: II. Determinants of short-term intraindividual variability. , 1995, American journal of respiratory and critical care medicine.

[9]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[10]  Lene Theil Skovgaard,et al.  Progress of emphysema in severe α1-Antitrypsin Deficiency as Assessed by Annual CT , 1997 .

[11]  W. Bailey,et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.

[12]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[13]  Dai-ichi Nuclear Accident,et al.  The International Commission on Radiological Protection , 1963, Nature.

[14]  H A Vrooman,et al.  Assessment of the progression of emphysema by quantitative analysis of spirometrically gated computed tomography images. , 1996, Investigative radiology.

[15]  R. Stockley,et al.  Alpha-1-antitrypsin deficiency: what next? , 2000, Thorax.